Journey Medical
DERM
21 hedge funds and large institutions have $5.85M invested in Journey Medical in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 3 closing their positions.
123% more capital invested
Capital invested by funds: $2.63M → $5.85M (+$3.22M)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
5% more funds holding
Funds holding: 20 → 21 (+1)
3.48% more ownership
Funds ownership: 13.63% → 17.11% (+3.5%)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.29M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$380K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$115K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$89.4K |
| 5 |
Millennium Management
New York
|
+$32.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$724K |
| 2 |
First Manhattan
New York
|
-$56.1K |
| 3 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$27.4K |
| 4 |
Neuberger Berman Group
New York
|
-$20.8K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$19.1K |
DERM Hedge Fund Activity: Q3 2023 in Review
21 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Journey Medical (DERM) for Q3 2023, worth a combined $5.85M — up 123% from $2.63M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new DERM positions and 3 closed out — a net gain of 2 holders — while 6 added to existing stakes and 7 trimmed.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $1.29M. The largest seller was B. Riley Financial, cutting an estimated $724K.
- 21 institutional investors held Journey Medical (DERM) as of Q3 2023, up from 20 in Q2 2023.
- Funds reported $5.85M of Journey Medical stock for Q3 2023, up 123% quarter-over-quarter.
- 5 funds opened new Journey Medical positions in Q3 2023 and 3 closed out, a net change of +2 holders.
- The largest Journey Medical buyer in Q3 2023 was Tang Capital Management, an estimated $1.29M added.
- The largest Journey Medical seller in Q3 2023 was B. Riley Financial, an estimated $724K sold.
Based on aggregated 13F filings for Q3 2023.